Jack Cook

2.9k total citations
77 papers, 1.8k citations indexed

About

Jack Cook is a scholar working on Pediatrics, Perinatology and Child Health, Statistics and Probability and Pharmacology. According to data from OpenAlex, Jack Cook has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pediatrics, Perinatology and Child Health, 16 papers in Statistics and Probability and 15 papers in Pharmacology. Recurrent topics in Jack Cook's work include Statistical Methods in Clinical Trials (16 papers), Pharmaceutical studies and practices (16 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Jack Cook is often cited by papers focused on Statistical Methods in Clinical Trials (16 papers), Pharmaceutical studies and practices (16 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Jack Cook collaborates with scholars based in United States, United Kingdom and Switzerland. Jack Cook's co-authors include Edward J. Randinitis, Howard N. Bockbrader, Susan Hurst, Edward L. Posvar, Christine Alvey, Caroline A. Lee, Allen J. Sedman, Yunhui Wu, James E. Polli and David E. Smith and has published in prestigious journals such as Neurology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jack Cook

75 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jack Cook United States	24	496	486	465	303	235	77	1.8k
Joseph A. Grillo United States	15	619 1.2×	459 0.9×	404 0.9×	311 1.0×	233 1.0×	28	2.0k
S-M Huang United States	15	685 1.4×	611 1.3×	534 1.1×	322 1.1×	221 0.9×	16	1.8k
V W Steinijans Germany	27	345 0.7×	232 0.5×	395 0.8×	222 0.7×	285 1.2×	80	2.3k
Bart A. Ploeger Netherlands	26	498 1.0×	364 0.7×	274 0.6×	630 2.1×	230 1.0×	67	2.3k
Thomas Kerbusch Netherlands	22	359 0.7×	347 0.7×	239 0.5×	411 1.4×	239 1.0×	47	1.9k
Vikram Sinha United States	27	460 0.9×	669 1.4×	338 0.7×	469 1.5×	167 0.7×	76	2.4k
William R. Gillespie United States	25	301 0.6×	238 0.5×	209 0.4×	253 0.8×	325 1.4×	65	2.2k
William H. Barr United States	24	233 0.5×	282 0.6×	341 0.7×	309 1.0×	274 1.2×	60	1.7k
Thorsten Lehr Germany	30	632 1.3×	528 1.1×	283 0.6×	470 1.6×	309 1.3×	120	3.8k
Carl C. Peck United States	32	703 1.4×	387 0.8×	589 1.3×	496 1.6×	370 1.6×	108	3.3k

Countries citing papers authored by Jack Cook

Since Specialization

Citations

This map shows the geographic impact of Jack Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Cook more than expected).

Fields of papers citing papers by Jack Cook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Cook. The network helps show where Jack Cook may publish in the future.

Co-authorship network of co-authors of Jack Cook

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Cook. A scholar is included among the top collaborators of Jack Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Cook. Jack Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haertter, Sebastian, et al.. (2025). Representation of Older Adult Patients in Clinical Trials. Clinical and Translational Science. 18(11). e70407–e70407.

Schug, Barbara, Erem Bilensoy, Jack Cook, et al.. (2025). The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference. European Journal of Pharmaceutical Sciences. 212. 107129–107129.

Galluppi, Gerald R., Malidi Ahamadi, Nageshwar Budha, et al.. (2024). Considerations for Industry—Preparing for the FDA Model‐Informed Drug Development (MIDD) Paired Meeting Program. Clinical Pharmacology & Therapeutics. 116(2). 282–288. 6 indexed citations

Taskar, Kunal S., Xinning Yang, Sibylle Neuhoff, et al.. (2022). Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective. Clinical Pharmacology & Therapeutics. 112(3). 573–592. 23 indexed citations

Masters, Joanna C., et al.. (2022). Ensuring diversity in clinical trials: The role of clinical pharmacology. Contemporary Clinical Trials. 118. 106807–106807. 13 indexed citations

Darwich, Adam S., Thomas M. Polasek, Jeffrey K Aronson, et al.. (2020). Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy. The Annual Review of Pharmacology and Toxicology. 61(1). 225–245. 109 indexed citations

Selen, Arzu, Anette Müllertz, Filippos Kesisoglou, et al.. (2020). Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products. The AAPS Journal. 22(5). 97–97. 3 indexed citations

Cook, Jack. (2015). A Six-Stage Business Continuity and Disaster Recovery Planning Cycle. S.A.M. advanced management journal. 80(3). 23. 29 indexed citations

Lee, Caroline A., Tasha K. Ritchie, Aleksandra Galetin, et al.. (2015). Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design. Drug Metabolism and Disposition. 43(4). 490–509. 108 indexed citations

10.

Lee, Caroline A., Jack Cook, Eric L. Reyner, & Dennis A. Smith. (2010). P-glycoprotein related drug interactions: clinical importance and a consideration of disease states. Expert Opinion on Drug Metabolism & Toxicology. 6(5). 603–619. 58 indexed citations

11.

Cook, Jack, et al.. (2010). Cook JA, Copeland ME, Corey L, Buffington E, Jonikas JA, Curtis LC, Grey DD, Nichols WH 『ピア(当事者)主導のサービスに対する科学的根拠の開発:2州の取り組みにおける,元気回復行動プラン(WRAP)教育後の参加者の変化』'Developing the evidence base for peer-led services: changes among participants following wellness recovery action planning (WRAP) eEducation in two statewide initiatives' (海外の精神障害リハビリテーション研究の紹介). 14(2). 190–192. 1 indexed citations

12.

Fahmi, Odette A., Susan Hurst, David R. Plowchalk, et al.. (2009). Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction. Drug Metabolism and Disposition. 37(8). 1658–1666. 167 indexed citations

13.

Williams, J. Andrew, Keith Johnson, Joseph Paulauskis, & Jack Cook. (2006). So Many Studies, Too Few Subjects: Establishing Functional Relevance of Genetic Polymorphisms on Pharmacokinetics. The Journal of Clinical Pharmacology. 46(3). 258–264. 21 indexed citations

14.

Lockwood, Peter, Jack Cook, Wayne Ewy, & Jaap W. Mandema. (2003). The Use of Clinical Trial Simulation to Support Dose Selection: Application to Development of a New Treatment for Chronic Neuropathic Pain. Pharmaceutical Research. 20(11). 1752–1759. 32 indexed citations

15.

Williams, J. Andrew, Jack Cook, & Susan Hurst. (2003). A SIGNIFICANT DRUG-METABOLIZING ROLE FOR CYP3A5?. Drug Metabolism and Disposition. 31(12). 1526–1531. 34 indexed citations

16.

Barrett, Jeffrey S., Vijay Batra, Andrew Chow, et al.. (2000). Update to the PhRMA Perspective on Population and Individual Bioequivalence. The Journal of Clinical Pharmacology. 40(6). 571–572. 5 indexed citations

17.

Reed, Rachel, et al.. (1999). Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration. Journal of Clinical Pharmacy and Therapeutics. 24(2). 125–132. 3 indexed citations

18.

Cook, Jack, et al.. (1998). Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeys. Biopharmaceutics & Drug Disposition. 19(3). 185–191. 2 indexed citations

19.

Lutz, Robert J., Alan H. Epstein, Jack Cook, & Robert L. Dedrick. (1995). Anin VitroFlow Model to Study Streaming during Pelvic Intra-arterial Drug Infusions. Gynecologic Oncology. 59(2). 288–296. 6 indexed citations

20.

Cook, Jack, et al.. (1992). Determination of cicletanine in human plasma by high-performance liquid chromatography using automated column switching. Journal of Chromatography B Biomedical Sciences and Applications. 573(1). 93–98. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact